Mustang Bio (MBIO)
(Delayed Data from NSDQ)
$0.31 USD
-0.02 (-5.36%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $0.31 0.00 (-0.19%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MBIO 0.31 -0.02(-5.36%)
Will MBIO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MBIO
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Mustang (MBIO) Up 9% on Rare Blood Cancer Study's Upbeat Data
MBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Mustang Bio, Inc. (MBIO) Could Surge 331.15%: Read This Before Placing a Bet
Wall Street Analysts Believe Mustang Bio, Inc. (MBIO) Could Rally 711.55%: Here's is How to Trade
Here's Why Mustang Bio, Inc. (MBIO) Looks Ripe for Bottom Fishing
Other News for MBIO
MindBio Partners with Haywood for Investment Strategy
MindBio Therapeutics Appoints Haywood Securities to Conduct Strategic Investment Advisory
Mustang Bio files to sell 6.5M shares by holders
Mustang Bio files to sell 6.5M shares of common stock for holders
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules